Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Hancock Jaffe Laboratories Inc. (HJLI)

0.421   0.001 (0.19%) 09-20 00:56
Open: 0.4144 Pre. Close: 0.4202
High: 0.474 Low: 0.4144
Volume: 3,405,562 Market Cap: 16M
Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.471 - 0.474 0.474 - 0.476
Low: 0.404 - 0.407 0.407 - 0.41
Close: 0.416 - 0.421 0.421 - 0.424

Technical analysis

as of: 2020-09-18 4:31:49 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 0.71     One year: 0.95
Support: Support1: 0.27    Support2: 0.23
Resistance: Resistance1: 0.60    Resistance2: 0.81
Pivot: 0.42
Moving Average: MA(5): 0.46     MA(20): 0.41
MA(100): 0.39     MA(250): 0.49
MACD: MACD(12,26): 0.02     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 36.59     %D(3): 40.69
RSI: RSI(14): 51.50
52-week: High: 0.95  Low: 0.21  Change(%): -54.3
Average Vol(K): 3-Month: 1226293  10-Days: 467294

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
HJLI has closed above bottom band by 47.9%. Bollinger Bands are 25.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 18 Sep 2020
Hancock Jaffe Laboratories Inc. (HJLI) 14-day ATR is 0.08: This Stock is Set to Soar Above its Peers - News Daemon

Thu, 17 Sep 2020
At $0.43 Price, Hancock Jaffe Laboratories, Inc. (HJLI) Sits And Waits For Direction - Stocks Register

Mon, 14 Sep 2020
Hancock Jaffe Laboratories Inc. [HJLI] Stock trading around $0.56 per share: What’s Next? - The DBT News

Thu, 10 Sep 2020
Hancock Jaffe Laboratories Inc. (HJLI) is 9.86% away from 50-day simple Moving Average despite all headwinds - News Daemon

Fri, 04 Sep 2020
Hancock Jaffe Laboratories, Inc. (HJLI): Significant Improvements, Worth Considering - Stocks Register

Tue, 01 Sep 2020
Hancock Jaffe Laboratories Inc. (NASDAQ:HJLI) is Holding Steady - The Oracle Dispatch

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 38
Shares Float (M) 31
% Held by Insiders 22.44
% Held by Institutions 1.27
Shares Short (K) 2,070
Shares Short P. Month (K) 735

Stock Financials

EPS -0.364
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.010
Profit Margin
Operating Margin
Return on Assets (ttm) -75.1
Return on Equity (ttm) -274.5
Qtrly Rev. Growth
Gross Profit (p.s.) -0.057
Sales Per Share
EBITDA (p.s.) -0.169
Qtrly Earnings Growth
Operating Cash Flow (M) -5
Levered Free Cash Flow (M) -3

Stock Valuations

PE Ratio -1.15
PEG Ratio
Price to Book value 42.00
Price to Sales
Price to Cash Flow -2.95

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.